Innospec (IOSP) EBIT (2010 - 2026)

Innospec (IOSP) has 17 years of EBIT data on file, last reported at $36.5 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 14.12% year-over-year to $36.5 million; the trailing twelve-month figure through Mar 2026 stood at $123.5 million (down 27.31% YoY), and the FY2025 full-year result was $129.5 million, down 27.21% from the prior year.
• EBIT declined to $36.5 million in Q1 2026, from $46.8 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $50.5 million in Q1 2024 to a low of $5.9 million in Q3 2025.
• A 5-year average of $40.8 million and a median of $42.5 million in 2025 frame the typical range for EBIT.
• Across the five-year window, EBIT jumped 59.55% in 2022 and plunged 87.06% in 2025, its largest moves.
• Tracing IOSP's EBIT over 5 years: stood at $46.6 million in 2022, then fell by 4.51% to $44.5 million in 2023, then declined by 7.64% to $41.1 million in 2024, then gained by 13.87% to $46.8 million in 2025, then declined by 22.01% to $36.5 million in 2026.
• Business Quant data shows IOSP's EBIT at $36.5 million in Q1 2026, $46.8 million in Q4 2025, and $5.9 million in Q3 2025.